CVE-2016-0211

Description

IBM DB2 9.7 through FP11, 9.8, 10.1 through FP5, and 10.5 through FP7 on Linux, UNIX, and Windows allows remote authenticated users to cause a denial of service (daemon crash) via a crafted DRDA message.

Category

4.3
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 1.55% Top 20%
Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www-01.ibm.com/support/docview.wss?uid=swg1IT12488 vendor advisory
http://www.securitytracker.com/id/1035660 vdb entry
http://www-01.ibm.com/support/docview.wss?uid=swg1IT12487 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg1IT13350 vendor advisory
http://www.securityfocus.com/bid/85979 vdb entry
http://www-01.ibm.com/support/docview.wss?uid=swg21979984 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg1IT12462 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2016-0211?
CVE-2016-0211 has been scored as a medium severity vulnerability.
How to fix CVE-2016-0211?
To fix CVE-2016-0211, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2016-0211 being actively exploited in the wild?
It is possible that CVE-2016-0211 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.